Skip to content
value.today

Gynesonics, Inc.

Total raised
$294 M
8 rounds on record
Latest round
$92 M
Apr 2023
First round on record
Nov 2009
Today
Acquired
Acquired by Hologic, Inc.

Acquired

Matched to this startup by its exact name; the buyer's report is the source.

Acquisition of Gynesonics, Inc.
AcquiredBuyerAcquisition dateCompletionPriceStakeSource
Gynesonics, IncHologic, Inc.2025—$341 M—Annual report

Funding rounds

8 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Gynesonics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$92 MNo. 8$50 to $250 million

Gynesonics, Inc.: Raise no. 8, Apr 2023

Investors in this round

13 investors had bought by the notice of Nov 6, 2023: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$92 M of $92 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Louis Baldino · Executive Officer, Director
  • Robert Brown · Executive Officer
  • Alexander Schmitz · Director
  • David Pacitti · Director
  • Greg Greifeld · Director
  • Hugo Harrod · Director
  • Joyce Erony · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The amount sold includes $25,000,000 in converted debt.”

Signed by "Louis ""Skip"" Baldino", Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 6, 2023. Read the notice at the SEC.

equitySEC
Dec 2021$33 MNo. 7$10 to $50 million

Gynesonics, Inc.: Raise no. 7, Dec 2021

Investors in this round

18 investors had bought by the notice of Dec 29, 2021: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $50 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Includes the issuance of shares of Series B, C, D, E, F, and F-1 Prime Preferred Stock and Series C Prime Preferred Warrants in exchange for Series A,B,C,D,E,F and F-1 Preferred Stock and Series C War
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Owens · Executive Officer, Director
  • Jordan Bajor · Executive Officer
  • Robert Brown · Executive Officer
  • Chandra Leo · Director
  • David Neustaedter · Director
  • David Pacitti · Director
  • Jeffrey Schwartz · Director
  • Joyce Erony · Director
  • Karen Talmadge · Director
  • Mike Carusi · Director
  • Robert O'Holla · Director
  • Susan Stimson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes the dollar amount from the conversion of the principal and interest of certain convertible notes.”

Signed by Robert S. Brown, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 29, 2021. Read the notice at the SEC.

equity, optionsSEC
Dec 2018$75 MNo. 6$50 to $250 million

Gynesonics, Inc.: Raise no. 6, Dec 2018

Investors in this round

21 investors had bought by the notice of Jan 3, 2019: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$75 M of $77 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher M. Owens · Executive Officer, Director
  • Chandra M. Leo · Director
  • David M. Neustaedter · Director
  • Doug M. Fisher · Director
  • Jeffrey M. Schwartz · Director
  • Karen M. Talmadge · Director
  • Ken M. Haas · Director
  • Mike M. Carusi · Director
  • Robert M. O'Holla · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes the dollar amount from the conversion of the principal and interest of certain convertible promissory notes.”
  • On the use of proceeds: “Working capital and general corporate purposes.”

Signed by Christopher M. Owens, President & CEO. Source: SEC Form D, newest notice filed Jan 3, 2019. Read the notice at the SEC.

equitySEC
Jul 2015$43 MNo. 5$10 to $50 million

Gynesonics, Inc.: Raise no. 5, Jul 2015

Investors in this round

16 investors had bought by the notice of Jul 29, 2015: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$43 M of $47 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Owens · Executive Officer, Director
  • Chandra P. Leo · Director
  • Doug H. Fisher · Director
  • Karen H. Talmadge · Director
  • Ken Haas · Director
  • Mike H. Carusi · Director
  • Robert H. O'Holla · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes payment in cash and by the conversion of the principal and interest of certain notes.”
  • On the use of proceeds: “The proceeds will be used for general corporate purposes.”

Signed by Christopher M. Owens, Ceo. Source: SEC Form D, newest notice filed Jul 29, 2015. Read the notice at the SEC.

equitySEC
Feb 2013$28 MNo. 4$10 to $50 million

Gynesonics, Inc.: Raise no. 4, Feb 2013

Investors in this round

16 investors had bought by the notice of Jul 9, 2014: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $35 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher M. Owens · Executive Officer, Director
  • Chandra P. Leo · Director
  • Doug M. Fisher · Director
  • Jonathan M. MacQuitty · Director
  • Karen M. Talmadge · Director
  • Ken M. Haas · Director
  • Mike M. Carusi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher M. Owens, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 9, 2014. Read the notice at the SEC.

equity, debtSEC
Feb 2012$5 MNo. 3$2 to $10 million

Gynesonics, Inc.: Raise no. 3, Feb 2012

Investors in this round

8 investors had bought by the notice of Feb 22, 2012: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Darrin Uecker · Executive Officer, Director
  • Doug Fisher · Director
  • Jonathan MacQuitty · Director
  • Karen Talmadge · Director
  • Ken Haas · Director
  • Tom Rodgers · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Darrin Uecker, Ceo. Source: SEC Form D, newest notice filed Feb 22, 2012. Read the notice at the SEC.

debt, optionsSEC
May 2010$16 MNo. 2$10 to $50 million

Gynesonics, Inc.: Raise no. 2, May 2010

Investors in this round

7 investors had bought by the notice of Jul 30, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $21 M offered; $5 M still to sell
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Darrin Uecker · Executive Officer, Director
  • Jonathan McQuitty · Director
  • Karen Talmadge · Director
  • Ken Haas · Director
  • Linda Grais · Director
  • Tom Rodgers · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jordan Bajor, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jul 30, 2010. Read the notice at the SEC.

equitySEC
Nov 2009$2 MNo. 1Under $2 million

Gynesonics, Inc.: Raise no. 1, Nov 2009

Investors in this round

7 investors had bought by the notice of Nov 17, 2009: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Darrin Uecker · Executive Officer, Director
  • Jonathan McQuitty · Director
  • Karen Talmadge · Director
  • Ken Haas · Director
  • Linda Grais · Director
  • Tom Rodgers · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jordan Bajor, Secretary. Source: SEC Form D, newest notice filed Nov 17, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Gynesonics, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2023).

    SEC Form D · Nov 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2023

That is all the official record says: Gynesonics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: the address on record now leads to another company's site.

Investors#

No investor of Gynesonics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 8 rounds above had up to 21 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Gynesonics, Inc.
NameRoleNamed in
Louis BaldinoExecutive officerNov 2023
Robert BrownExecutive officerNov 2023
Christopher OwensExecutive officerDec 2021
Jordan BajorExecutive officerDec 2021
Christopher M. OwensExecutive officerJan 2019
Darrin UeckerExecutive officerFeb 2013
Alexander SchmitzDirectorNov 2023
David PacittiDirectorNov 2023
Greg GreifeldDirectorNov 2023
Hugo HarrodDirectorNov 2023
Joyce EronyDirectorNov 2023
Louis BaldinoDirectorNov 2023
Chandra LeoDirectorDec 2021
Christopher OwensDirectorDec 2021
David NeustaedterDirectorDec 2021
Jeffrey SchwartzDirectorDec 2021
Karen TalmadgeDirectorDec 2021
Mike CarusiDirectorDec 2021
Robert O'HollaDirectorDec 2021
Susan StimsonDirectorDec 2021
Chandra M. LeoDirectorJan 2019
Christopher M. OwensDirectorJan 2019
David M. NeustaedterDirectorJan 2019
Doug M. FisherDirectorJan 2019
Jeffrey M. SchwartzDirectorJan 2019
Karen M. TalmadgeDirectorJan 2019
Ken M. HaasDirectorJan 2019
Mike M. CarusiDirectorJan 2019
Robert M. O'HollaDirectorJan 2019
Chandra P. LeoDirectorJul 2015
Doug H. FisherDirectorJul 2015
Karen H. TalmadgeDirectorJul 2015
Ken HaasDirectorJul 2015
Mike H. CarusiDirectorJul 2015
Robert H. O'HollaDirectorJul 2015
Jonathan M. MacQuittyDirectorJul 2014
Darrin UeckerDirectorFeb 2013
Doug FisherDirectorFeb 2013
Jonathan MacQuittyDirectorFeb 2013
Tom RodgersDirectorFeb 2012

About

Company in Redwood City, United States.

Acquired (Jan 1, 2025). Acquired by Hologic, Inc..